Estimates of worldwide burden of cancer in 2008: GLOBOCAN, Int J Cancer, vol.127, pp.2893-917, 2008. ,
Good clinical practice recommendations for the use of PET/CT in oncology, Eur J Nucl Med Mol Imaging, vol.47, pp.28-50, 2020. ,
Role of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography in gastrointestinal cancers, Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver, vol.47, pp.443-54, 2015. ,
Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence, Eur J Gastroenterol Hepatol, vol.23, pp.275-81, 2011. ,
Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 tesla MR with extracellular and reticulo-endothelial cell specific contrast agents, Abdom Imaging, vol.35, pp.511-532, 2010. ,
Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and wholebody FDG PET, AJR Am J Roentgenol, vol.185, pp.239-285, 2005. ,
Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: a systematic review and meta-analysis, J Magn Reson Imaging, vol.31, pp.19-31, 2010. ,
Immuno-PET for clinical theranostic approaches, Int J Mol Sci, vol.18, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01636873
, Front Pharmacol, vol.6, p.54, 2015.
The usefulness of immunohistochemistry in sporadic colorectal cancer, Romanian J Morphol Embryol Rev Roum Morphol Embryol, vol.49, pp.525-560, 2008. ,
Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule, Cell, vol.57, pp.90970-90977, 1989. ,
Stably tethered multifunctional structures of defined composition made by the dock and lock method for use in cancer targeting, Proc Natl Acad Sci, vol.103, pp.6841-6847, 2006. ,
Immuno-PET using anticarcinoembryonic antigen bispecific antibody and 68Ga-labeled peptide in metastatic medullary thyroid carcinoma: clinical optimization of the Pretargeting parameters in a first-in-human trial, J Nucl Med, vol.57, pp.1505-1516, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01415668
Initial clinical results of a novel immuno-PET theranostic probe in HER2-negative breast cancer, J Nucl Med, 2020. ,
URL : https://hal.archives-ouvertes.fr/inserm-02512957
Sensitivity of pretargeted immunoPET using 68Ga-peptide to detect colonic carcinoma liver metastases in a murine xenograft model: comparison with 18FDG PET-CT, Oncotarget, vol.9, pp.27502-27515, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-01981491
Optimization of hapten-peptide labeling for pretargeted immunoPET of bispecific antibody using generator-produced 68Ga, J Nucl Med, vol.52, pp.555-564, 2011. ,
Importance of CEA and CA 15-3 during disease progression in metastatic breast cancer patients, Anticancer Res, vol.27, pp.1963-1971, 2007. ,
Effective dose to adult patients from 338 radiopharmaceuticals estimated using ICRP biokinetic data, ICRP/ICRU computational reference phantoms and ICRP 2007 tissue weighting factors, EJNMMI Phys, vol.1, issue.9, 2014. ,
Pharmacokinetics and d o s i m e t r y s t u d i e s f o r, CEA-expressing advanced lung cancer patients, vol.2, p.84, 2015. ,
Sacituzumab govitecan-hziy in refractory metastatic triple-negative breast cancer, N Engl J Med, vol.380, pp.741-51, 2019. ,
Development of an imaging-guided CEA-pretargeted radionuclide treatment of advanced colorectal cancer: first clinical results, Br J Cancer, vol.109, pp.934-976, 2013. ,